世界の静脈内ヒト免疫グロブリン市場予測（～2028年）：液体、粉末

• 英文タイトル：Global Intravenous Human Immunoglobulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8866 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

静脈内ヒト免疫グロブリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の静脈内ヒト免疫グロブリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 静脈内ヒト免疫グロブリン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・液体、粉末 用途別セグメントは次のように区分されます。 ・病院、専門クリニック、その他 世界の静脈内ヒト免疫グロブリン市場の主要な市場プレーヤーは以下のとおりです。 ・Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Tiantan Biological(Sinopharm)、Taibang Biologic Group 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、静脈内ヒト免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な静脈内ヒト免疫グロブリンメーカーの企業概要、2019年～2022年までの静脈内ヒト免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な静脈内ヒト免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別静脈内ヒト免疫グロブリンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの静脈内ヒト免疫グロブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での静脈内ヒト免疫グロブリン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および静脈内ヒト免疫グロブリンの産業チェーンを掲載しています。 ・第13、14、15章では、静脈内ヒト免疫グロブリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Tiantan Biological(Sinopharm)、Taibang Biologic Group ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：液体、粉末 ・用途別分析2017年-2028年：病院、専門クリニック、その他 ・静脈内ヒト免疫グロブリンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・静脈内ヒト免疫グロブリンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・静脈内ヒト免疫グロブリンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・静脈内ヒト免疫グロブリンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・静脈内ヒト免疫グロブリンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Intravenous Human Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intravenous Human Immunoglobulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Intravenous Human Immunoglobulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intravenous Human Immunoglobulin include Baxter, Grifols, CSL, Octapharma, and Biotest, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intravenous Human Immunoglobulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid
Powder
Market segment by Application can be divided into
Hospital
Specialty Clinic
Others
The key market players for global Intravenous Human Immunoglobulin market are listed below:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Tiantan Biological(Sinopharm)
Taibang Biologic Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Human Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous Human Immunoglobulin, with price, sales, revenue and global market share of Intravenous Human Immunoglobulin from 2019 to 2022.
Chapter 3, the Intravenous Human Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Human Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intravenous Human Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravenous Human Immunoglobulin.
Chapter 13, 14, and 15, to describe Intravenous Human Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Intravenous Human Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous Human Immunoglobulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous Human Immunoglobulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Intravenous Human Immunoglobulin Market Size & Forecast
1.4.1 Global Intravenous Human Immunoglobulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intravenous Human Immunoglobulin Sales in Volume (2017-2028)
1.4.3 Global Intravenous Human Immunoglobulin Price (2017-2028)
1.5 Global Intravenous Human Immunoglobulin Production Capacity Analysis
1.5.1 Global Intravenous Human Immunoglobulin Total Production Capacity (2017-2028)
1.5.2 Global Intravenous Human Immunoglobulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous Human Immunoglobulin Market Drivers
1.6.2 Intravenous Human Immunoglobulin Market Restraints
1.6.3 Intravenous Human Immunoglobulin Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Intravenous Human Immunoglobulin Product and Services
2.1.4 Baxter Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Intravenous Human Immunoglobulin Product and Services
2.2.4 Grifols Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Intravenous Human Immunoglobulin Product and Services
2.3.4 CSL Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Intravenous Human Immunoglobulin Product and Services
2.4.4 Octapharma Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Intravenous Human Immunoglobulin Product and Services
2.5.4 Biotest Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Intravenous Human Immunoglobulin Product and Services
2.6.4 Kedrion Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Intravenous Human Immunoglobulin Product and Services
2.7.4 Hualan Bio Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Intravenous Human Immunoglobulin Product and Services
2.8.4 CNBG Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Product and Services
2.9.4 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Intravenous Human Immunoglobulin Product and Services
2.10.4 CBPO Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group Intravenous Human Immunoglobulin Product and Services
2.11.4 LFB Group Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL Intravenous Human Immunoglobulin Product and Services
2.12.4 BPL Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Tiantan Biological(Sinopharm)
2.13.1 Tiantan Biological(Sinopharm) Details
2.13.2 Tiantan Biological(Sinopharm) Major Business
2.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product and Services
2.13.4 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Taibang Biologic Group
2.14.1 Taibang Biologic Group Details
2.14.2 Taibang Biologic Group Major Business
2.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Product and Services
2.14.4 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intravenous Human Immunoglobulin Breakdown Data by Manufacturer
3.1 Global Intravenous Human Immunoglobulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intravenous Human Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intravenous Human Immunoglobulin
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Human Immunoglobulin Manufacturer Market Share in 2021
3.4.2 Top 6 Intravenous Human Immunoglobulin Manufacturer Market Share in 2021
3.5 Global Intravenous Human Immunoglobulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intravenous Human Immunoglobulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous Human Immunoglobulin Market Size by Region
4.1.1 Global Intravenous Human Immunoglobulin Sales in Volume by Region (2017-2028)
4.1.2 Global Intravenous Human Immunoglobulin Revenue by Region (2017-2028)
4.2 North America Intravenous Human Immunoglobulin Revenue (2017-2028)
4.3 Europe Intravenous Human Immunoglobulin Revenue (2017-2028)
4.4 Asia-Pacific Intravenous Human Immunoglobulin Revenue (2017-2028)
4.5 South America Intravenous Human Immunoglobulin Revenue (2017-2028)
4.6 Middle East and Africa Intravenous Human Immunoglobulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intravenous Human Immunoglobulin Sales in Volume by Type (2017-2028)
5.2 Global Intravenous Human Immunoglobulin Revenue by Type (2017-2028)
5.3 Global Intravenous Human Immunoglobulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intravenous Human Immunoglobulin Sales in Volume by Application (2017-2028)
6.2 Global Intravenous Human Immunoglobulin Revenue by Application (2017-2028)
6.3 Global Intravenous Human Immunoglobulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous Human Immunoglobulin Sales by Type (2017-2028)
7.2 North America Intravenous Human Immunoglobulin Sales by Application (2017-2028)
7.3 North America Intravenous Human Immunoglobulin Market Size by Country
7.3.1 North America Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
7.3.2 North America Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous Human Immunoglobulin Sales by Type (2017-2028)
8.2 Europe Intravenous Human Immunoglobulin Sales by Application (2017-2028)
8.3 Europe Intravenous Human Immunoglobulin Market Size by Country
8.3.1 Europe Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intravenous Human Immunoglobulin Sales by Type (2017-2028)
9.2 Asia-Pacific Intravenous Human Immunoglobulin Sales by Application (2017-2028)
9.3 Asia-Pacific Intravenous Human Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Intravenous Human Immunoglobulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intravenous Human Immunoglobulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intravenous Human Immunoglobulin Sales by Type (2017-2028)
10.2 South America Intravenous Human Immunoglobulin Sales by Application (2017-2028)
10.3 South America Intravenous Human Immunoglobulin Market Size by Country
10.3.1 South America Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
10.3.2 South America Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2017-2028)
11.2 Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2017-2028)
11.3 Middle East & Africa Intravenous Human Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Intravenous Human Immunoglobulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intravenous Human Immunoglobulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intravenous Human Immunoglobulin
12.3 Intravenous Human Immunoglobulin Production Process
12.4 Intravenous Human Immunoglobulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intravenous Human Immunoglobulin Typical Distributors
13.3 Intravenous Human Immunoglobulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---